ロード中...
Epigenetic mechanisms underlying prostate cancer radioresistance
Radiotherapy (RT) is one of the mainstay treatments for prostate cancer (PCa), a highly prevalent neoplasm among males worldwide. About 30% of newly diagnosed PCa patients receive RT with a curative intent. However, biochemical relapse occurs in 20–40% of advanced PCa treated with RT either alone or...
保存先:
| 出版年: | Clin Epigenetics |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8186094/ https://ncbi.nlm.nih.gov/pubmed/34103085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-021-01111-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|